Loading...

Robert D Cardiff

Title(s)Professor Emeritus, SCHOOL OF VETERINARY MEDICINE
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The Center for Translational Genomic Phenotyping
    NIH/NCI U01CA141582Sep 1, 2009 - Aug 31, 2014
    Role: Principal Investigator
    Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance
    NIH/NCI U01CA141541Aug 17, 2009 - Jul 31, 2014
    Role: Co-Principal Investigator
    25TH IABCR CONGRESS CONFERENCE: PERSONALIZED BREAST CANCER THERAPY
    NIH/NCI R13CA124375Sep 12, 2006 - Aug 31, 2007
    Role: Principal Investigator
    PRECLINICAL MODELS OF BREAST CANCER
    NIH/NCI R13CA104880Aug 1, 2003 - Jul 31, 2004
    Role: Principal Investigator
    BIOLOGY OF NEOPLASTIC TRANSFORMATION IN BREAST CANCER
    NIH/NCI R01CA089140Jan 25, 2001 - Dec 31, 2006
    Role: Principal Investigator
    MOUSE MODELS FOR PROSTATE CARCINOGENESIS
    NIH/NCI R01CA060775May 16, 1994 - Feb 28, 1998
    Role: Principal Investigator
    PROTOONCOGENES AND MULTISTEP MAMMARY CARCINOGENESIS
    NIH/NCI R01CA054284Apr 1, 1991 - Mar 31, 1996
    Role: Principal Investigator
    MURINE IMMUNODEFICIENCY LENTIVIRUS MODEL FOR AIDS
    NIH/NIAID R01AI029799Apr 1, 1990 - Mar 31, 1994
    Role: Principal Investigator
    RADIATION ACTIVATION OF ONCOGENES
    NIH/NCI R01CA036493Dec 1, 1983 - Jun 30, 1989
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Olson A, Le V, Aldahl J, Yu EJ, Hooker E, He Y, Lee DH, Kim WK, Cardiff RD, Geradts J, Sun Z. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. PLoS Genet. 2019 Oct; 15(10):e1008451. PMID: 31658259.
      View in: PubMed
    2. He Y, Johnson DT, Yang JS, Wu H, You S, Yoon J, Lee DH, Kim WK, Aldahl J, Le V, Hooker E, Yu EJ, Geradts J, Cardiff RD, Sun Z. Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate. Oncogene. 2019 Sep; 38(38):6507-6520. PMID: 31358900.
      View in: PubMed
    3. Lee DH, Yu EJ, Aldahl J, Yang J, He Y, Hooker E, Le V, Mi J, Olson A, Wu H, Geradts J, Xiao GQ, Gonzalgo ML, Cardiff RD, Sun Z. Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate. PLoS One. 2019; 14(1):e0211153. PMID: 30677079.
      View in: PubMed
    4. El Ayachi I, Fatima I, Wend P, Alva-Ornelas JA, Runke S, Kuenzinger WL, Silva J, Silva W, Gray JK, Lehr S, Barch HC, Krutilina RI, White AC, Cardiff R, Yee LD, Yang L, O'Regan RM, Lowry WE, Seagroves TN, Seewaldt V, Krum SA, Miranda-Carboni GA. The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer. Cancer Res. 2019 03 01; 79(5):982-993. PMID: 30563890.
      View in: PubMed
    5. Elmore SA, Cardiff R, Cesta MF, Gkoutos GV, Hoehndorf R, Keenan CM, McKerlie C, Schofield PN, Sundberg JP, Ward JM. A Review of Current Standards and the Evolution of Histopathology Nomenclature for Laboratory Animals. ILAR J. 2018 12 01; 59(1):29-39. PMID: 30476141.
      View in: PubMed
    6. Aeffner F, Adissu HA, Boyle MC, Cardiff RD, Hagendorn E, Hoenerhoff MJ, Klopfleisch R, Newbigging S, Schaudien D, Turner O, Wilson K. Digital Microscopy, Image Analysis, and Virtual Slide Repository. ILAR J. 2018 12 01; 59(1):66-79. PMID: 30535284.
      View in: PubMed
    7. Gattelli A, García Solá ME, Roloff TC, Cardiff RD, Kordon EC, Chodosh LA, Hynes NE. Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition. Oncogene. 2018 07; 37(29):4046-4054. PMID: 29695833.
      View in: PubMed
    8. Mori H, Cardiff RD, Borowsky AD. Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression. Front Cell Dev Biol. 2018; 6:35. PMID: 29651417.
      View in: PubMed
    9. Mori H, Chen JQ, Cardiff RD, Pénzváltó Z, Hubbard NE, Schuetter L, Hovey RC, Trott JF, Borowsky AD. Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype. Breast Cancer Res. 2017 Sep 02; 19(1):102. PMID: 28865492.
      View in: PubMed
    10. Bui T, Schade B, Cardiff RD, Aina OH, Sanguin-Gendreau V, Muller WJ. ß-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model. Proc Natl Acad Sci U S A. 2017 01 31; 114(5):E707-E716. PMID: 28096336.
      View in: PubMed
    11. Schmitz J, Schwab J, Schwenck J, Chen Q, Quintanilla-Martinez L, Hahn M, Wietek B, Schwenzer N, Staebler A, Kohlhofer U, Aina OH, Hubbard NE, Reischl G, Borowsky AD, Brucker S, Nikolaou K, la Fougère C, Cardiff RD, Pichler BJ, Schmid AM. Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study. Cancer Res. 2016 09 15; 76(18):5512-22. PMID: 27466286.
      View in: PubMed
    12. Turpin J, Ling C, Crosby EJ, Hartman ZC, Simond AM, Chodosh LA, Rennhack JP, Andrechek ER, Ozcelik J, Hallett M, Mills GB, Cardiff RD, Gray JW, Griffith OL, Muller WJ. The ErbB2?Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene. 2016 11 24; 35(47):6053-6064. PMID: 27157621.
      View in: PubMed
    13. Mori H, Cardiff RD. Methods of Immunohistochemistry and Immunofluorescence: Converting Invisible to Visible. Methods Mol Biol. 2016; 1458:1-12. PMID: 27581010.
      View in: PubMed
    14. Bao L, Cardiff RD, Steinbach P, Messer KS, Ellies LG. Multipotent luminal mammary cancer stem cells model tumor heterogeneity. Breast Cancer Res. 2015 Oct 14; 17(1):137. PMID: 26467658.
      View in: PubMed
    15. Adams CJ, Yu JS, Mao JH, Jen KY, Costes SV, Wade M, Shoemake J, Aina OH, Del Rosario R, Menchavez PT, Cardiff RD, Wahl GM, Balmain A. The Trp53 delta proline (Trp53?P) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor development. Mol Carcinog. 2016 09; 55(9):1387-96. PMID: 26310697.
      View in: PubMed
    16. Koren S, Reavie L, Couto JP, De Silva D, Stadler MB, Roloff T, Britschgi A, Eichlisberger T, Kohler H, Aina O, Cardiff RD, Bentires-Alj M. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 2015 Sep 03; 525(7567):114-8. PMID: 26266975.
      View in: PubMed
    17. Rowson-Hodel AR, Manjarin R, Trott JF, Cardiff RD, Borowsky AD, Hovey RC. Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. BMC Cancer. 2015 Jul 31; 15:562. PMID: 26228788.
      View in: PubMed
    18. Engelberg JA, Retallack H, Balassanian R, Dowsett M, Zabaglo L, Ram AA, Apple SK, Bishop JW, Borowsky AD, Carpenter PM, Chen YY, Datnow B, Elson S, Hasteh F, Lin F, Moatamed NA, Zhang Y, Cardiff RD. "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Hum Pathol. 2015 Nov; 46(11):1694-704. PMID: 26410019.
      View in: PubMed
    19. Mori H, Soonsawad P, Schuetter L, Chen Q, Hubbard NE, Cardiff RD, Borowsky AD. Introduction of Zinc-salt Fixation for Effective Detection of Immune Cell-related Markers by Immunohistochemistry. Toxicol Pathol. 2015 Aug; 43(6):883-9. PMID: 26157038.
      View in: PubMed
    20. Chen JQ, Mori H, Cardiff RD, Trott JF, Hovey RC, Hubbard NE, Engelberg JA, Tepper CG, Willis BJ, Khan IH, Ravindran RK, Chan SR, Schreiber RD, Borowsky AD. Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent. PLoS One. 2015; 10(6):e0129895. PMID: 26075897.
      View in: PubMed
    21. Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, Tozeren A, Knudsen ES, Arnold A, Pestell RG. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget. 2015 Apr 20; 6(11):8525-38. PMID: 25940700.
      View in: PubMed
    22. Fite BZ, Wong A, Liu Y, Mahakian LM, Tam SM, Aina O, Hubbard NE, Borowsky A, Cardiff RD, Dumont E, Ferrara KW. Magnetic resonance imaging assessment of effective ablated volume following high intensity focused ultrasound. PLoS One. 2015; 10(3):e0120037. PMID: 25785992.
      View in: PubMed
    23. Jeon YJ, Khelifa S, Ratnikov B, Scott DA, Feng Y, Parisi F, Ruller C, Lau E, Kim H, Brill LM, Jiang T, Rimm DL, Cardiff RD, Mills GB, Smith JW, Osterman AL, Kluger Y, Ronai ZA. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies. Cancer Cell. 2015 Mar 09; 27(3):354-69. PMID: 25759021.
      View in: PubMed
    24. Zhang J, Xu E, Ren C, Yan W, Zhang M, Chen M, Cardiff RD, Imai DM, Wisner E, Chen X. Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors. Proc Natl Acad Sci U S A. 2014 Dec 30; 111(52):18637-42. PMID: 25512531.
      View in: PubMed
    25. Mounir Z, Lin F, Lin VG, Korn JM, Yu Y, Valdez R, Aina OH, Buchwalter G, Jaffe AB, Korpal M, Zhu P, Brown M, Cardiff RD, Rocnik JL, Yang Y, Pagliarini R. TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation. Oncogene. 2015 Jul; 34(29):3815-25. PMID: 25263440.
      View in: PubMed
    26. Hollern DP, Honeysett J, Cardiff RD, Andrechek ER. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Mol Cell Biol. 2014 Sep; 34(17):3229-43. PMID: 24934442.
      View in: PubMed
    27. Cardiff RD, Miller CH, Munn RJ. Manual immunohistochemistry staining of mouse tissues using the avidin-biotin complex (ABC) technique. Cold Spring Harb Protoc. 2014 Jun 02; 2014(6):659-62. PMID: 24890206.
      View in: PubMed
    28. Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014 Jun 02; 2014(6):655-8. PMID: 24890205.
      View in: PubMed
    29. Cardiff RD, Miller CH, Munn RJ. Analysis of mouse model pathology: a primer for studying the anatomic pathology of genetically engineered mice. Cold Spring Harb Protoc. 2014 Jun 02; 2014(6):561-80. PMID: 24890215.
      View in: PubMed
    30. Cardiff RD, Miller CH, Munn RJ. Mouse tissue fixation. Cold Spring Harb Protoc. 2014 May 01; 2014(5). PMID: 24786501.
      View in: PubMed
    31. Cardiff RD, Miller CH, Munn RJ. Limited mouse necropsy. Cold Spring Harb Protoc. 2014 May 01; 2014(5). PMID: 24786500.
      View in: PubMed
    32. Engelberg JA, Giberson RT, Young LJ, Hubbard NE, Cardiff RD. The use of mouse models of breast cancer and quantitative image analysis to evaluate hormone receptor antigenicity after microwave-assisted formalin fixation. J Histochem Cytochem. 2014 May; 62(5):319-34. PMID: 24682322.
      View in: PubMed
    33. Feigin ME, Akshinthala SD, Araki K, Rosenberg AZ, Muthuswamy LB, Martin B, Lehmann BD, Berman HK, Pietenpol JA, Cardiff RD, Muthuswamy SK. Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancer. Cancer Res. 2014 Jun 01; 74(11):3180-94. PMID: 24662921.
      View in: PubMed
    34. Cardiff RD, Borowsky AD. At last: classification of human mammary cells elucidates breast cancer origins. J Clin Invest. 2014 Feb; 124(2):478-80. PMID: 24463442.
      View in: PubMed
    35. Paoli EE, Ingham ES, Zhang H, Mahakian LM, Fite BZ, Gagnon MK, Tam S, Kheirolomoom A, Cardiff RD, Ferrara KW. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. J Control Release. 2014 Mar 28; 178:108-17. PMID: 24434424.
      View in: PubMed
    36. Cardiff RD, Miller CH, Munn RJ, Galvez JJ. Structured reporting in anatomic pathology for coclinical trials: the caELMIR model. Cold Spring Harb Protoc. 2014 Jan 01; 2014(1):32-43. PMID: 24173313.
      View in: PubMed
    37. Haricharan S, Hein SM, Dong J, Toneff MJ, Aina OH, Rao PH, Cardiff RD, Li Y. Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. Oncogene. 2014 Dec 11; 33(50):5729-39. PMID: 24317513.
      View in: PubMed
    38. Meyer DS, Koren S, Leroy C, Brinkhaus H, Müller U, Klebba I, Müller M, Cardiff RD, Bentires-Alj M. Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R. Oncogenesis. 2013 Sep 30; 2:e74. PMID: 24080956.
      View in: PubMed
    39. Aytes A, Mitrofanova A, Kinkade CW, Lefebvre C, Lei M, Phelan V, LeKaye HC, Koutcher JA, Cardiff RD, Califano A, Shen MM, Abate-Shen C. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci U S A. 2013 Sep 10; 110(37):E3506-15. PMID: 23918374.
      View in: PubMed
    40. Fujita M, Ieguchi K, Cedano-Prieto DM, Fong A, Wilkerson C, Chen JQ, Wu M, Lo SH, Cheung AT, Wilson MD, Cardiff RD, Borowsky AD, Takada YK, Takada Y. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R. J Biol Chem. 2013 Jul 05; 288(27):19593-603. PMID: 23696648.
      View in: PubMed
    41. Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R, Simons BW, Ward JM, Robinson BD, Chu GC, Loda M, Thomas G, Borowsky A, Cardiff RD. Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res. 2013 May 01; 73(9):2718-36. PMID: 23610450.
      View in: PubMed
    42. Kurpios NA, Girgis-Gabardo A, Hallett RM, Rogers S, Gludish DW, Kockeritz L, Woodgett J, Cardiff R, Hassell JA. Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts. PLoS One. 2013; 8(3):e58151. PMID: 23555570.
      View in: PubMed
    43. Knight JF, Lesurf R, Zhao H, Pinnaduwage D, Davis RR, Saleh SM, Zuo D, Naujokas MA, Chughtai N, Herschkowitz JI, Prat A, Mulligan AM, Muller WJ, Cardiff RD, Gregg JP, Andrulis IL, Hallett MT, Park M. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proc Natl Acad Sci U S A. 2013 Apr 02; 110(14):E1301-10. PMID: 23509284.
      View in: PubMed
    44. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, Shen MM. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol. 2013 Mar; 15(3):274-83. PMID: 23434823.
      View in: PubMed
    45. Cardiff RD, Hubbard NE, Engelberg JA, Munn RJ, Miller CH, Walls JE, Chen JQ, Velásquez-García HA, Galvez JJ, Bell KJ, Beckett LA, Li YJ, Borowsky AD. Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers. Lab Invest. 2013 Apr; 93(4):480-97. PMID: 23399853.
      View in: PubMed
    46. Teplova I, Lozy F, Price S, Singh S, Barnard N, Cardiff RD, Birge RB, Karantza V. ATG proteins mediate efferocytosis and suppress inflammation in mammary involution. Autophagy. 2013 Apr; 9(4):459-75. PMID: 23380905.
      View in: PubMed
    47. D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, Cardiff RD, Bell K, Young LJ, Simin K, Bachelder RE, Delrow J, Dawson A, Yee LD, Mrózek K, Clay TM, Osada T, Seewaldt VL. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS One. 2012; 7(9):e45684. PMID: 23049838.
      View in: PubMed
    48. Berryhill GE, Gloviczki JM, Trott JF, Aimo L, Kraft J, Cardiff RD, Paul CT, Petrie WK, Lock AL, Hovey RC. Diet-induced metabolic change induces estrogen-independent allometric mammary growth. Proc Natl Acad Sci U S A. 2012 Oct 02; 109(40):16294-9. PMID: 22988119.
      View in: PubMed
    49. Rudmann D, Cardiff R, Chouinard L, Goodman D, Küttler K, Marxfeld H, Molinolo A, Treumann S, Yoshizawa K. Proliferative and nonproliferative lesions of the rat and mouse mammary, Zymbal's, preputial, and clitoral glands. Toxicol Pathol. 2012 Aug; 40(6 Suppl):7S-39S. PMID: 22949413.
      View in: PubMed
    50. Wang J, Kobayashi T, Floc'h N, Kinkade CW, Aytes A, Dankort D, Lefebvre C, Mitrofanova A, Cardiff RD, McMahon M, Califano A, Shen MM, Abate-Shen C. B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer. Cancer Res. 2012 Sep 15; 72(18):4765-76. PMID: 22836754.
      View in: PubMed
    51. Floc'h N, Kinkade CW, Kobayashi T, Aytes A, Lefebvre C, Mitrofanova A, Cardiff RD, Califano A, Shen MM, Abate-Shen C. Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model. Cancer Res. 2012 Sep 01; 72(17):4483-93. PMID: 22815528.
      View in: PubMed
    52. Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, Wang W, Loch AJ, Deng T, Zhao W, Cardiff RD, Yoon K, Gaiano N, Ling V, Beyene J, Zacksenhaus E, Gridley T, Leong WL, Guidos CJ, Perou CM, Egan SE. Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell. 2012 May 15; 21(5):626-41. PMID: 22624713.
      View in: PubMed
    53. Gibby K, You WK, Kadoya K, Helgadottir H, Young LJ, Ellies LG, Chang Y, Cardiff RD, Stallcup WB. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan. Breast Cancer Res. 2012 Apr 24; 14(2):R67. PMID: 22531600.
      View in: PubMed
    54. Watson KD, Lai CY, Qin S, Kruse DE, Lin YC, Seo JW, Cardiff RD, Mahakian LM, Beegle J, Ingham ES, Curry FR, Reed RK, Ferrara KW. Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors. Cancer Res. 2012 Mar 15; 72(6):1485-93. PMID: 22282664.
      View in: PubMed
    55. Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, Welch MJ, Cardiff RD, Schreiber RD. STAT1-deficient mice spontaneously develop estrogen receptor a-positive luminal mammary carcinomas. Breast Cancer Res. 2012 Jan 20; 14(1):R16. PMID: 22264274.
      View in: PubMed
    56. Couto SS, Bolon B, Cardiff RD. Morphologic manifestations of gene-specific molecular alterations ("genetic addictions") in mouse models of disease. Vet Pathol. 2012 Jan; 49(1):116-29. PMID: 22173978.
      View in: PubMed
    57. Caskey CF, Hlawitschka M, Qin S, Mahakian LM, Cardiff RD, Boone JM, Ferrara KW. An open environment CT-US fusion for tissue segmentation during interventional guidance. PLoS One. 2011; 6(11):e27372. PMID: 22132098.
      View in: PubMed
    58. Cardiff RD, Couto S, Bolon B. Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells. Breast Cancer Res. 2011 Oct 25; 13(5):216. PMID: 22067349.
      View in: PubMed
    59. Leung JY, Andrechek ER, Cardiff RD, Nevins JR. Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene. 2012 May 17; 31(20):2545-54. PMID: 21996730.
      View in: PubMed
    60. Cardiff RD, Kenney N. A compendium of the mouse mammary tumor biologist: from the initial observations in the house mouse to the development of genetically engineered mice. Cold Spring Harb Perspect Biol. 2011 Jun 01; 3(6). PMID: 20961975.
      View in: PubMed
    61. Meyer DS, Brinkhaus H, Müller U, Müller M, Cardiff RD, Bentires-Alj M. Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res. 2011 Jul 01; 71(13):4344-51. PMID: 21482677.
      View in: PubMed
    62. Bolon B, Altrock B, Barthold SW, Baumgarth N, Besselsen D, Boivin G, Boyd KL, Brayton C, Cardiff RD, Couto S, Eaton KA, Foreman O, Griffey SM, La Perle K, Lairmore MD, Liu C, Meyerholz DK, Nikitin AY, Schoeb TR, Schwahn D, Sellers RS, Sundberg JP, Tolwani R, Valli VE, Zink MC. Advancing translational research. Science. 2011 Mar 25; 331(6024):1516-7. PMID: 21436422.
      View in: PubMed
    63. Yeh ES, Yang TW, Jung JJ, Gardner HP, Cardiff RD, Chodosh LA. Hunk is required for HER2/neu-induced mammary tumorigenesis. J Clin Invest. 2011 Mar; 121(3):866-79. PMID: 21393859.
      View in: PubMed
    64. Kheirolomoom A, Mahakian LM, Lai CY, Lindfors HA, Seo JW, Paoli EE, Watson KD, Haynam EM, Ingham ES, Xing L, Cheng RH, Borowsky AD, Cardiff RD, Ferrara KW. Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm. 2010 Dec 06; 7(6):1948-58. PMID: 20925429.
      View in: PubMed
    65. Rygh CB, Qin S, Seo JW, Mahakian LM, Zhang H, Adamson R, Chen JQ, Borowsky AD, Cardiff RD, Reed RK, Curry FR, Ferrara KW. Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET. Clin Cancer Res. 2011 Feb 01; 17(3):550-9. PMID: 21106723.
      View in: PubMed
    66. Kladney RD, Cardiff RD, Kwiatkowski DJ, Chiang GG, Weber JD, Arbeit JM, Lu ZH. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Cancer Res. 2010 Nov 01; 70(21):8937-47. PMID: 20940396.
      View in: PubMed
    67. Kalashnikova EV, Revenko AS, Gemo AT, Andrews NP, Tepper CG, Zou JX, Cardiff RD, Borowsky AD, Chen HW. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res. 2010 Nov 15; 70(22):9402-12. PMID: 20864510.
      View in: PubMed
    68. Hebbard L, Cecena G, Golas J, Sawada J, Ellies LG, Charbono A, Williams R, Jimenez RE, Wankell M, Arndt KT, DeJoy SQ, Rollins RA, Diesl V, Follettie M, Chen L, Rosfjord E, Cardiff RD, Komatsu M, Boschelli F, Oshima RG. Control of mammary tumor differentiation by SKI-606 (bosutinib). Oncogene. 2011 Jan 20; 30(3):301-12. PMID: 20818417.
      View in: PubMed
    69. Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, Krajewski S, Mercola D, Carpenter PM, Bowtell D, Ronai ZA. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell. 2010 Jul 13; 18(1):23-38. PMID: 20609350.
      View in: PubMed
    70. Cardiff RD. The pathology of EMT in mouse mammary tumorigenesis. J Mammary Gland Biol Neoplasia. 2010 Jun; 15(2):225-33. PMID: 20521088.
      View in: PubMed
    71. Bolon B, Barthold SW, Boyd KL, Brayton C, Cardiff RD, Cork LC, Eaton KA, Schoeb TR, Sundberg JP, Ward JM. Male mice not alone in research. Science. 2010 May 28; 328(5982):1103. PMID: 20508110.
      View in: PubMed
    72. Pond AC, Herschkowitz JI, Schwertfeger KL, Welm B, Zhang Y, York B, Cardiff RD, Hilsenbeck S, Perou CM, Creighton CJ, Lloyd RE, Rosen JM. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Res. 2010 Jun 15; 70(12):4868-79. PMID: 20501844.
      View in: PubMed
    73. La Merrill M, Harper R, Birnbaum LS, Cardiff RD, Threadgill DW. Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice. Environ Health Perspect. 2010 May; 118(5):596-601. PMID: 20435547.
      View in: PubMed
    74. Cardiff RD, Borowsky AD. Precancer: sequentially acquired or predetermined? Toxicol Pathol. 2010 Jan; 38(1):171-9. PMID: 20019354.
      View in: PubMed
    75. Fathers KE, Rodrigues S, Zuo D, Murthy IV, Hallett M, Cardiff R, Park M. CrkII transgene induces atypical mammary gland development and tumorigenesis. Am J Pathol. 2010 Jan; 176(1):446-60. PMID: 20008144.
      View in: PubMed
    76. Radaelli E, Damonte P, Cardiff RD. Epithelial-mesenchymal transition in mouse mammary tumorigenesis. Future Oncol. 2009 Oct; 5(8):1113-27. PMID: 19852725.
      View in: PubMed
    77. Trainor BC, Sweeney C, Cardiff R. Isolating the effects of social interactions on cancer biology. Cancer Prev Res (Phila). 2009 Oct; 2(10):843-6. PMID: 19789296.
      View in: PubMed
    78. Kheirolomoom A, Kruse DE, Qin S, Watson KE, Lai CY, Young LJ, Cardiff RD, Ferrara KW. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J Control Release. 2010 Jan 25; 141(2):128-36. PMID: 19748536.
      View in: PubMed
    79. Andrechek ER, Cardiff RD, Chang JT, Gatza ML, Acharya CR, Potti A, Nevins JR. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proc Natl Acad Sci U S A. 2009 Sep 22; 106(38):16387-92. PMID: 19805309.
      View in: PubMed
    80. Wertheim GB, Yang TW, Pan TC, Ramne A, Liu Z, Gardner HP, Dugan KD, Kristel P, Kreike B, van de Vijver MJ, Cardiff RD, Reynolds C, Chodosh LA. The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis. Proc Natl Acad Sci U S A. 2009 Sep 15; 106(37):15855-60. PMID: 19717424.
      View in: PubMed
    81. Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci U S A. 2009 Aug 04; 106(31):12903-8. PMID: 19617568.
      View in: PubMed
    82. Cardiff RD. How to phenotype a mouse. Dis Model Mech. 2009 Jul-Aug; 2(7-8):317-21. PMID: 19553687.
      View in: PubMed
    83. Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res. 2009 May 15; 15(10):3256-64. PMID: 19447866.
      View in: PubMed
    84. Schade B, Rao T, Dourdin N, Lesurf R, Hallett M, Cardiff RD, Muller WJ. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis. J Biol Chem. 2009 Jul 10; 284(28):19018-26. PMID: 19435886.
      View in: PubMed
    85. King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH, Taylor BS, Sander C, Cardiff RD, Couto SS, Gerald WL, Sawyers CL. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet. 2009 May; 41(5):524-6. PMID: 19396167.
      View in: PubMed
    86. Radaelli E, Arnold A, Papanikolaou A, Garcia-Fernandez RA, Mattiello S, Scanziani E, Cardiff RD. Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. Vet Pathol. 2009 Jul; 46(4):736-45. PMID: 19276050.
      View in: PubMed
    87. Fleisch MC, Chou YC, Cardiff RD, Asaithambi A, Shyamala G. Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. Mol Hum Reprod. 2009 Apr; 15(4):241-9. PMID: 19224949.
      View in: PubMed
    88. Workman HC, Miller JK, Ingalla EQ, Kaur RP, Yamamoto DI, Beckett LA, Young LJ, Cardiff RD, Borowsky AD, Carraway KL, Sweeney C, Carraway KL. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Breast Cancer Res. 2009; 11(5):R70. PMID: 19761616.
      View in: PubMed
    89. Cardiff RD. One-health wonders. Interview by R. Scott Nolen. J Am Vet Med Assoc. 2008 Dec 15; 233(12):1828-9. PMID: 19097330.
      View in: PubMed
    90. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol. 2009 Jan 10; 27(2):279-88. PMID: 19064970.
      View in: PubMed
    91. Couto SS, Cao M, Duarte PC, Banach-Petrosky W, Wang S, Romanienko P, Wu H, Cardiff RD, Abate-Shen C, Cunha GR. Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer. Differentiation. 2009 Jan; 77(1):103-11. PMID: 19281769.
      View in: PubMed
    92. Miller JK, Shattuck DL, Ingalla EQ, Yen L, Borowsky AD, Young LJ, Cardiff RD, Carraway KL, Sweeney C. Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Res. 2008 Oct 15; 68(20):8286-94. PMID: 18922900.
      View in: PubMed
    93. Marlow R, Strickland P, Lee JS, Wu X, Pebenito M, Binnewies M, Le EK, Moran A, Macias H, Cardiff RD, Sukumar S, Hinck L. SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res. 2008 Oct 01; 68(19):7819-27. PMID: 18829537.
      View in: PubMed
    94. Ince TA, Ward JM, Valli VE, Sgroi D, Nikitin AY, Loda M, Griffey SM, Crum CP, Crawford JM, Bronson RT, Cardiff RD. Do-it-yourself (DIY) pathology. Nat Biotechnol. 2008 Sep; 26(9):978-9; discussion 979. PMID: 18779800.
      View in: PubMed
    95. Damonte P, Hodgson JG, Chen JQ, Young LJ, Cardiff RD, Borowsky AD. Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Res. 2008; 10(3):R50. PMID: 18522749.
      View in: PubMed
    96. Dourdin N, Schade B, Lesurf R, Hallett M, Munn RJ, Cardiff RD, Muller WJ. Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis. Cancer Res. 2008 Apr 01; 68(7):2122-31. PMID: 18381417.
      View in: PubMed
    97. Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res. 2008 Mar 01; 68(5):1407-16. PMID: 18316604.
      View in: PubMed
    98. Ursini-Siegel J, Hardy WR, Zuo D, Lam SH, Sanguin-Gendreau V, Cardiff RD, Pawson T, Muller WJ. ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J. 2008 Mar 19; 27(6):910-20. PMID: 18273058.
      View in: PubMed
    99. Cardiff RD. Genomic pathology for genomic biology. Pathologica. 2008 Feb; 100(1):3-5. PMID: 18686517.
      View in: PubMed
    100. Couto SS, Cardiff RD. The genomic revolution and endocrine pathology. Endocr Pathol. 2008; 19(3):139-47. PMID: 18758692.
      View in: PubMed
    101. Debies MT, Gestl SA, Mathers JL, Mikse OR, Leonard TL, Moody SE, Chodosh LA, Cardiff RD, Gunther EJ. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. J Clin Invest. 2008 Jan; 118(1):51-63. PMID: 18060046.
      View in: PubMed
    102. Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain A. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol. 2008 Jan; 172(1):236-46. PMID: 18156212.
      View in: PubMed
    103. Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC, Muller WJ. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A. 2007 Dec 18; 104(51):20302-7. PMID: 18056629.
      View in: PubMed
    104. Cardiff RD, Ward JM, Barthold SW. 'One medicine---one pathology': are veterinary and human pathology prepared? Lab Invest. 2008 Jan; 88(1):18-26. PMID: 18040269.
      View in: PubMed
    105. Valli T, Barthold SW, Ward JE, Brayton C, Nikitin A, Borowsky AD, Bronson RT, Cardiff RD, Sundberg J, Ince T. Over 60% of NIH extramural funding involves animal-related research. Vet Pathol. 2007 Nov; 44(6):962-3, author reply 963-4. PMID: 18039915.
      View in: PubMed
    106. Beliakoff J, Lee J, Ueno H, Aiyer A, Weissman IL, Barsh GS, Cardiff RD, Sun Z. The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol Cell Biol. 2008 Jan; 28(1):282-92. PMID: 17967885.
      View in: PubMed
    107. Damonte P, Gregg JP, Borowsky AD, Keister BA, Cardiff RD. EMT tumorigenesis in the mouse mammary gland. Lab Invest. 2007 Dec; 87(12):1218-26. PMID: 17922020.
      View in: PubMed
    108. Schade B, Lam SH, Cernea D, Sanguin-Gendreau V, Cardiff RD, Jung BL, Hallett M, Muller WJ. Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles. Cancer Res. 2007 Aug 15; 67(16):7579-88. PMID: 17699761.
      View in: PubMed
    109. Barthold SW, Borowsky AD, Brayton C, Bronson R, Cardiff RD, Griffey SM, Ince TA, Nikitin AY, Sundberg J, Valli VE, Ward JM. From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest. 2007 Jul; 19(4):455-6. PMID: 17609364.
      View in: PubMed
    110. Lu ZH, Wright JD, Belt B, Cardiff RD, Arbeit JM. Hypoxia-inducible factor-1 facilitates cervical cancer progression in human papillomavirus type 16 transgenic mice. Am J Pathol. 2007 Aug; 171(2):667-81. PMID: 17600126.
      View in: PubMed
    111. Cardiff RD. Pathologists needed to cope with mutant mice. Nature. 2007 May 31; 447(7144):528. PMID: 17538596.
      View in: PubMed
    112. Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ. Insights from transgenic mouse models of ERBB2-induced breast cancer. Nat Rev Cancer. 2007 05; 7(5):389-97. PMID: 17446858.
      View in: PubMed
    113. Davie SA, Maglione JE, Manner CK, Young D, Cardiff RD, MacLeod CL, Ellies LG. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 2007 Apr; 16(2):193-201. PMID: 17206489.
      View in: PubMed
    114. Cardiff RD. Epilog: comparative medicine, one medicine and genomic pathology. Breast Dis. 2007; 28:107-10. PMID: 18057547.
      View in: PubMed
    115. Cardiff RD, Kenney N. Mouse mammary tumor biology: a short history. Adv Cancer Res. 2007; 98:53-116. PMID: 17433908.
      View in: PubMed
    116. Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Heterogeneity of mammary lesions represent molecular differences. BMC Cancer. 2006 Dec 05; 6:275. PMID: 17147824.
      View in: PubMed
    117. Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Res. 2006 Dec 01; 66(23):11279-86. PMID: 17145873.
      View in: PubMed
    118. Shyamala G, Chou YC, Cardiff RD, Vargis E. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology. Cancer Res. 2006 Nov 01; 66(21):10391-8. PMID: 17079459.
      View in: PubMed
    119. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink J, Krimpenfort P, Peterse JL, Cardiff RD, Berns A, Jonkers J. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006 Nov; 10(5):437-49. PMID: 17097565.
      View in: PubMed
    120. Fritz WA, Lin TM, Cardiff RD, Peterson RE. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis. 2007 Feb; 28(2):497-505. PMID: 17052998.
      View in: PubMed
    121. Cardiff RD, Gregg JP, Miller JW, Axelrod DE, Borowsky AD. Histopathology as a predictive biomarker: strengths and limitations. J Nutr. 2006 Oct; 136(10):2673S-5S. PMID: 16988145.
      View in: PubMed
    122. Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia. 2006 Sep; 8(9):708-15. PMID: 16984728.
      View in: PubMed
    123. Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clin Cancer Res. 2006 Apr 15; 12(8):2613-21. PMID: 16638874.
      View in: PubMed
    124. Abbey CK, Borowsky AD, Gregg JP, Cardiff RD, Cherry SR. Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography. J Mammary Gland Biol Neoplasia. 2006 Apr; 11(2):137-49. PMID: 17091397.
      View in: PubMed
    125. Chodosh LA, Cardiff RD. In vivo imaging of the mammary gland: the shape of things to come. J Mammary Gland Biol Neoplasia. 2006 Apr; 11(2):101-2. PMID: 17089204.
      View in: PubMed
    126. Kwak EL, Kim S, Zhang J, Cardiff RD, Schmidt EV, Haber DA. Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant. Cancer Res. 2006 Feb 15; 66(4):1923-8. PMID: 16488990.
      View in: PubMed
    127. Cecena G, Wen F, Cardiff RD, Oshima RG. Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene. Am J Pathol. 2006 Jan; 168(1):310-20. PMID: 16400032.
      View in: PubMed
    128. Cardiff RD, Anver MR, Boivin GP, Bosenberg MW, Maronpot RR, Molinolo AA, Nikitin AY, Rehg JE, Thomas GV, Russell RG, Ward JM. Precancer in mice: animal models used to understand, prevent, and treat human precancers. Toxicol Pathol. 2006; 34(6):699-707. PMID: 17074738.
      View in: PubMed
    129. Hill R, Song Y, Cardiff RD, Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell. 2005 Dec 16; 123(6):1001-11. PMID: 16360031.
      View in: PubMed
    130. Cardiff RD. Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace? Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8534-7. PMID: 16361534.
      View in: PubMed
    131. Hill R, Song Y, Cardiff RD, Van Dyke T. Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. Cancer Res. 2005 Nov 15; 65(22):10243-54. PMID: 16288012.
      View in: PubMed
    132. Bilousova G, Marusyk A, Porter CC, Cardiff RD, DeGregori J. Impaired DNA replication within progenitor cell pools promotes leukemogenesis. PLoS Biol. 2005 Dec; 3(12):e401. PMID: 16277552.
      View in: PubMed
    133. Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, Cardiff RD, Newman RA, Yang P, Thaler HT, Muller WJ, Hudis C, Brown AM, Hla T, Subbaramaiah K, Dannenberg AJ. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res. 2005 Nov 01; 65(21):10113-9. PMID: 16267038.
      View in: PubMed
    134. Borges HL, Bird J, Wasson K, Cardiff RD, Varki N, Eckmann L, Wang JY. Tumor promotion by caspase-resistant retinoblastoma protein. Proc Natl Acad Sci U S A. 2005 Oct 25; 102(43):15587-92. PMID: 16227443.
      View in: PubMed
    135. Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ. Breast Cancer Res. 2005; 7(6):R881-9. PMID: 16280035.
      View in: PubMed
    136. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD, Chodosh LA. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 2005 Sep; 8(3):197-209. PMID: 16169465.
      View in: PubMed
    137. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res. 2005 Jul 01; 65(13):5792-801. PMID: 15994955.
      View in: PubMed
    138. Simin K, Hill R, Song Y, Zhang Q, Bash R, Cardiff RD, Yin C, Xiao A, McCarthy K, van Dyke T. Deciphering cancer complexities in genetically engineered mice. Cold Spring Harb Symp Quant Biol. 2005; 70:283-90. PMID: 16869764.
      View in: PubMed
    139. Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, Sherr DH, Seldin DC. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol. 2005; 33(6):726-37. PMID: 16263698.
      View in: PubMed
    140. Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ, Cardiff RD, Gregg JP. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis. 2005; 22(1):47-59. PMID: 16132578.
      View in: PubMed
    141. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M, Lee H, Shih WJ, Cardiff RD, Shen MM, Abate-Shen C. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A. 2004 Dec 07; 101(49):17204-9. PMID: 15569926.
      View in: PubMed
    142. Iavnilovitch E, Cardiff RD, Groner B, Barash I. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer. 2004 Nov 20; 112(4):607-19. PMID: 15382041.
      View in: PubMed
    143. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 2004 Oct 28; 431(7012):1112-7. PMID: 15475948.
      View in: PubMed
    144. Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol. 2004 Nov; 2(11):e332. PMID: 15455033.
      View in: PubMed
    145. Gum JR, Hicks JW, Crawley SC, Yang SC, Borowsky AD, Dahl CM, Kakar S, Kim DH, Cardiff RD, Kim YS. Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Mol Cancer Res. 2004 Sep; 2(9):504-13. PMID: 15383629.
      View in: PubMed
    146. Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther. 2004 Aug; 3(8):941-53. PMID: 15299077.
      View in: PubMed
    147. Namba R, Maglione JE, Young LJ, Borowsky AD, Cardiff RD, MacLeod CL, Gregg JP. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Mol Cancer Res. 2004 Aug; 2(8):453-63. PMID: 15328372.
      View in: PubMed
    148. Abbey CK, Borowsky AD, McGoldrick ET, Gregg JP, Maglione JE, Cardiff RD, Cherry SR. In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proc Natl Acad Sci U S A. 2004 Aug 03; 101(31):11438-43. PMID: 15277673.
      View in: PubMed
    149. Borowsky AD, Munn RJ, Galvez JJ, Cardiff RD, Ward JM, Morse HC, Kogan SC, Aldape KD, Louis DN, Bosenberg MW. Mouse models of human cancers (part 3). Comp Med. 2004 Jun; 54(3):258-70. PMID: 15253271.
      View in: PubMed
    150. Scherl A, Li JF, Cardiff RD, Schreiber-Agus N. Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice. Prostate. 2004 Jun 01; 59(4):448-59. PMID: 15065094.
      View in: PubMed
    151. Lin SC, Lee KF, Nikitin AY, Hilsenbeck SG, Cardiff RD, Li A, Kang KW, Frank SA, Lee WH, Lee EY. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res. 2004 May 15; 64(10):3525-32. PMID: 15150107.
      View in: PubMed
    152. Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 2004 May 01; 64(9):3171-8. PMID: 15126356.
      View in: PubMed
    153. Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson EW, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, Rehm S, Rozengurt N, Schuller HM, Shmidt EN, Travis WD, Ward JM, Jacks T. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res. 2004 Apr 01; 64(7):2307-16. PMID: 15059877.
      View in: PubMed
    154. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 2004 Mar 15; 64(6):2270-305. PMID: 15026373.
      View in: PubMed
    155. Cardiff RD, Rosner A, Hogarth MA, Galvez JJ, Borowsky AD, Gregg JP. Validation: the new challenge for pathology. Toxicol Pathol. 2004 Mar-Apr; 32 Suppl 1:31-9. PMID: 15209401.
      View in: PubMed
    156. Saez E, Rosenfeld J, Livolsi A, Olson P, Lombardo E, Nelson M, Banayo E, Cardiff RD, Izpisua-Belmonte JC, Evans RM. PPAR gamma signaling exacerbates mammary gland tumor development. Genes Dev. 2004 Mar 01; 18(5):528-40. PMID: 15037548.
      View in: PubMed
    157. Jessen KA, Liu SY, Tepper CG, Karrim J, McGoldrick ET, Rosner A, Munn RJ, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res. 2004; 6(3):R157-69. PMID: 15084239.
      View in: PubMed
    158. Simin K, Wu H, Lu L, Pinkel D, Albertson D, Cardiff RD, Van Dyke T. pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol. 2004 Feb; 2(2):E22. PMID: 14966529.
      View in: PubMed
    159. Galvez JJ, Cardiff RD, Munn RJ, Borowsky AD. Mouse models of human cancers (Part 2). Comp Med. 2004 Feb; 54(1):13-5. PMID: 15027614.
      View in: PubMed
    160. Oshima RG, Lesperance J, Munoz V, Hebbard L, Ranscht B, Sharan N, Muller WJ, Hauser CA, Cardiff RD. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis. Cancer Res. 2004 Jan 01; 64(1):169-79. PMID: 14729621.
      View in: PubMed
    161. Gillgrass A, Cardiff RD, Sharan N, Kannan S, Muller WJ. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression. Oncogene. 2003 Dec 11; 22(57):9151-5. PMID: 14668796.
      View in: PubMed
    162. Man AK, Young LJ, Tynan JA, Lesperance J, Egeblad M, Werb Z, Hauser CA, Muller WJ, Cardiff RD, Oshima RG. Ets2-dependent stromal regulation of mouse mammary tumors. Mol Cell Biol. 2003 Dec; 23(23):8614-25. PMID: 14612405.
      View in: PubMed
    163. Greenwald RJ, Tumang JR, Sinha A, Currier N, Cardiff RD, Rothstein TL, Faller DV, Denis GV. E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood. 2004 Feb 15; 103(4):1475-84. PMID: 14563639.
      View in: PubMed
    164. Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD, Muller WJ. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Res. 2003 Aug 15; 63(16):4920-6. PMID: 12941816.
      View in: PubMed
    165. Ellies LG, Fishman M, Hardison J, Kleeman J, Maglione JE, Manner CK, Cardiff RD, MacLeod CL. Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. Int J Cancer. 2003 Aug 10; 106(1):1-7. PMID: 12794750.
      View in: PubMed
    166. Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol Cell Biol. 2003 Aug; 23(16):5738-54. PMID: 12897145.
      View in: PubMed
    167. Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD. Persistent mammary hyperplasia in FVB/N mice. Comp Med. 2003 Aug; 53(4):433-8. PMID: 14524420.
      View in: PubMed
    168. Wakefield LM, Thordarson G, Nieto AI, Shyamala G, Galvez JJ, Anver MR, Cardiff RD. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med. 2003 Aug; 53(4):424-32. PMID: 14524419.
      View in: PubMed
    169. Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res. 2003 Jul 15; 63(14):3886-90. PMID: 12873978.
      View in: PubMed
    170. Bierie B, Nozawa M, Renou JP, Shillingford JM, Morgan F, Oka T, Taketo MM, Cardiff RD, Miyoshi K, Wagner KU, Robinson GW, Hennighausen L. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene. 2003 Jun 19; 22(25):3875-87. PMID: 12813461.
      View in: PubMed
    171. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massagué J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A. 2003 Jul 08; 100(14):8430-5. PMID: 12808151.
      View in: PubMed
    172. Cardiff RD. Mouse models of human breast cancer. Comp Med. 2003 Jun; 53(3):250-3. PMID: 12868567.
      View in: PubMed
    173. Powell WC, Cardiff RD, Cohen MB, Miller GJ, Roy-Burman P. Mouse strains for prostate tumorigenesis based on genes altered in human prostate cancer. Curr Drug Targets. 2003 Apr; 4(3):263-79. PMID: 12643476.
      View in: PubMed
    174. Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD, Cardiff RD, Chodosh LA. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev. 2003 Feb 15; 17(4):488-501. PMID: 12600942.
      View in: PubMed
    175. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell. 2003 Feb; 3(2):117-30. PMID: 12620407.
      View in: PubMed
    176. Uehara N, Chou YC, Galvez JJ, de-Candia P, Cardiff RD, Benezra R, Shyamala G. Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast Cancer Res. 2003; 5(2):R25-9. PMID: 12631395.
      View in: PubMed
    177. Green JE, Cardiff R, Hennighausen L, Wakefield L, Wagner U, Lee E, Rosen J, Medina D, Nitkin A, Liu E. Validation of transgenic mammary cancer models: goals of the NCI Mouse Models of Human Cancer Consortium and the mammary cancer CD-ROM. Transgenic Res. 2002 Dec; 11(6):635-6. PMID: 12509138.
      View in: PubMed
    178. Chatterjee G, Rosner A, Han Y, Zelazny ET, Li B, Cardiff RD, Perkins AS. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. Am J Pathol. 2002 Dec; 161(6):2241-53. PMID: 12466138.
      View in: PubMed
    179. Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2002 Dec; 2(6):451-61. PMID: 12498714.
      View in: PubMed
    180. Song Z, Wu X, Powell WC, Cardiff RD, Cohen MB, Tin RT, Matusik RJ, Miller GJ, Roy-Burman P. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Res. 2002 Sep 01; 62(17):5096-105. PMID: 12208767.
      View in: PubMed
    181. Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE, Cardiff RD. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol. 2002 Sep; 161(3):1087-97. PMID: 12213737.
      View in: PubMed
    182. Huang J, Powell WC, Khodavirdi AC, Wu J, Makita T, Cardiff RD, Cohen MB, Sucov HM, Roy-Burman P. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res. 2002 Aug 15; 62(16):4812-9. PMID: 12183441.
      View in: PubMed
    183. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene. 2002 Aug 15; 21(36):5548-56. PMID: 12165853.
      View in: PubMed
    184. Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM, Cardiff RD. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol. 2002 Aug; 161(2):727-35. PMID: 12163397.
      View in: PubMed
    185. Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, Carter JS, de Coronado S, Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H, Jaffe ES, MacLennan IC, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF, Morse HC. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002 Jul 01; 100(1):238-45. PMID: 12070033.
      View in: PubMed
    186. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res. 2002 Jun 01; 62(11):2999-3004. PMID: 12036903.
      View in: PubMed
    187. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A. 2002 Mar 05; 99(5):2884-9. PMID: 11854455.
      View in: PubMed
    188. Cardiff RD, Bern HA, Faulkin LJ, Daniel CW, Smith GH, Young LJ, Medina D, Gardner MB, Wellings SR, Shyamala G, Guzman RC, Rajkumar L, Yang J, Thordarson G, Nandi S, MacLeod CL, Oshima RG, Man AK, Sawai ET, Gregg JP, Cheung AT, Lau DH. Contributions of mouse biology to breast cancer research. Comp Med. 2002 Feb; 52(1):12-31. PMID: 11900409.
      View in: PubMed
    189. Miyoshi K, Shillingford JM, Le Provost F, Gounari F, Bronson R, von Boehmer H, Taketo MM, Cardiff RD, Hennighausen L, Khazaie K. Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):219-24. PMID: 11773619.
      View in: PubMed
    190. Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. Cancer Res. 2001 Dec 15; 61(24):8811-9. PMID: 11751403.
      View in: PubMed
    191. Zhu JW, Field SJ, Gore L, Thompson M, Yang H, Fujiwara Y, Cardiff RD, Greenberg M, Orkin SH, DeGregori J. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol. 2001 Dec; 21(24):8547-64. PMID: 11713289.
      View in: PubMed
    192. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res. 2001 Nov 15; 61(22):8298-305. PMID: 11719463.
      View in: PubMed
    193. Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC. Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol Cell Biochem. 2001 Nov; 227(1-2):153-65. PMID: 11827167.
      View in: PubMed
    194. White DE, Cardiff RD, Dedhar S, Muller WJ. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene. 2001 Oct 25; 20(48):7064-72. PMID: 11704830.
      View in: PubMed
    195. Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, Arnold A. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53. Transgenic Res. 2001 Oct; 10(5):471-8. PMID: 11708657.
      View in: PubMed
    196. Cardiff RD, Wagner U, Hennighausen L. Mammary cancer in humans and mice: a tutorial for comparative pathology. Vet Pathol. 2001 Jul; 38(4):357-8. PMID: 11467469.
      View in: PubMed
    197. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene. 2001 May 31; 20(25):3247-57. PMID: 11423974.
      View in: PubMed
    198. Moser AR, Hegge LF, Cardiff RD. Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. Cancer Res. 2001 Apr 15; 61(8):3480-5. PMID: 11309311.
      View in: PubMed
    199. Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD, Muller WJ. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol. 2001 Mar; 21(5):1540-51. PMID: 11238891.
      View in: PubMed
    200. Lebel M, Cardiff RD, Leder P. Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase. Cancer Res. 2001 Mar 01; 61(5):1816-9. PMID: 11280729.
      View in: PubMed
    201. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol. 2001 Mar; 21(6):2203-12. PMID: 11238953.
      View in: PubMed
    202. D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med. 2001 Feb; 7(2):235-9. PMID: 11175856.
      View in: PubMed
    203. Cardiff RD. Validity of mouse mammary tumour models for human breast cancer: comparative pathology. Microsc Res Tech. 2001 Jan 15; 52(2):224-30. PMID: 11169869.
      View in: PubMed
    204. Zahnow CA, Cardiff RD, Laucirica R, Medina D, Rosen JM. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res. 2001 Jan 01; 61(1):261-9. PMID: 11196172.
      View in: PubMed
    205. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res. 2000 Nov 01; 60(21):6008-17. PMID: 11085521.
      View in: PubMed
    206. Cardiff RD, Moghanaki D, Jensen RA. Genetically engineered mouse models of mammary intraepithelial neoplasia. J Mammary Gland Biol Neoplasia. 2000 Oct; 5(4):421-37. PMID: 14973386.
      View in: PubMed
    207. Tennent BJ, Cardiff RD. Mice, mutations and mammary glands. Mol Med Today. 2000 Apr; 6(4):143-4. PMID: 10866490.
      View in: PubMed
    208. Cardiff RD, Wagner U, Hennighausen L. Mammary cancer in humans and mice: a tutorial for comparative pathology. The CD-ROM. J Mammary Gland Biol Neoplasia. 2000 Apr; 5(2):243-4. PMID: 11149576.
      View in: PubMed
    209. Shyamala G, Yang X, Cardiff RD, Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci U S A. 2000 Mar 28; 97(7):3044-9. PMID: 10737785.
      View in: PubMed
    210. Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci U S A. 2000 Mar 28; 97(7):3444-9. PMID: 10716706.
      View in: PubMed
    211. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene. 2000 Feb 21; 19(8):968-88. PMID: 10713680.
      View in: PubMed
    212. Rauh MJ, Blackmore V, Andrechek ER, Tortorice CG, Daly R, Lai VK, Pawson T, Cardiff RD, Siegel PM, Muller WJ. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein. Mol Cell Biol. 1999 Dec; 19(12):8169-79. PMID: 10567542.
      View in: PubMed
    213. Neznanov N, Man AK, Yamamoto H, Hauser CA, Cardiff RD, Oshima RG. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. Cancer Res. 1999 Sep 01; 59(17):4242-6. PMID: 10485465.
      View in: PubMed
    214. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM. Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999 Apr 15; 13(8):966-77. PMID: 10215624.
      View in: PubMed
    215. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J. 1999 Apr 15; 18(8):2149-64. PMID: 10205169.
      View in: PubMed
    216. Cardiff RD, Wellings SR. The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia. 1999 Jan; 4(1):105-22. PMID: 10219910.
      View in: PubMed
    217. Siminovitch KA, Lamhonwah AM, Somani AK, Cardiff R, Mills GB. Involvement of the SHP-1 tyrosine phosphatase in regulating B lymphocyte antigen receptor signaling, proliferation and transformation. Curr Top Microbiol Immunol. 1999; 246:291-7; discussion 298. PMID: 10396068.
      View in: PubMed
    218. Cheng AM, Saxton TM, Sakai R, Kulkarni S, Mbamalu G, Vogel W, Tortorice CG, Cardiff RD, Cross JC, Muller WJ, Pawson T. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell. 1998 Dec 11; 95(6):793-803. PMID: 9865697.
      View in: PubMed
    219. DiGiovanna MP, Lerman MA, Coffey RJ, Muller WJ, Cardiff RD, Stern DF. Active signaling by Neu in transgenic mice. Oncogene. 1998 Oct 08; 17(14):1877-84. PMID: 9778054.
      View in: PubMed
    220. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998 Jul; 176(1):206-15. PMID: 9618160.
      View in: PubMed
    221. Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene. 1998 Jun 11; 16(23):2965-74. PMID: 9662328.
      View in: PubMed
    222. Luster AD, Cardiff RD, MacLean JA, Crowe K, Granstein RD. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians. 1998 May-Jun; 110(3):183-96. PMID: 9625525.
      View in: PubMed
    223. Webster MA, Martin-Soudant N, Nepveu A, Cardiff RD, Muller WJ. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members. Oncogene. 1998 Apr 16; 16(15):1963-72. PMID: 9591780.
      View in: PubMed
    224. Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol. 1998 Apr; 18(4):2344-59. PMID: 9528804.
      View in: PubMed
    225. Estberg L, Case JT, Walters RF, Cardiff RD, Galuppo LD. Word search performance for diagnoses of equine surgical colics in free-text electronic patient records. Prev Vet Med. 1998 Feb 27; 34(2-3):161-74. PMID: 9604265.
      View in: PubMed
    226. Cardiff RD. Are the TDLU of the human the same as the LA of mice? J Mammary Gland Biol Neoplasia. 1998 Jan; 3(1):3-5. PMID: 10819500.
      View in: PubMed
    227. Deckardjanatpour K, Muller W, Chodosh L, Gardner H, Marquis S, Coffey R, Cardiff R. Differential expression of the neu transgene in murine mammary tissues. Int J Oncol. 1997 Aug; 11(2):235-41. PMID: 21528205.
      View in: PubMed
    228. Cheung A, Young L, Chen P, Chao C, Ndoye A, Barry P, Muller W, Cardiff R. Microcirculation and metastasis in a new mouse mammary tumor model system. Int J Oncol. 1997 Jul; 11(1):69-77. PMID: 21528182.
      View in: PubMed
    229. Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD, Meise KS, Li F, Halter SA, Coffey RJ. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol. 1996 Oct; 16(10):5726-36. PMID: 8816486.
      View in: PubMed
    230. Tehranian A, Morris DW, Min BH, Bird DJ, Cardiff RD, Barry PA. Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. Am J Pathol. 1996 Oct; 149(4):1177-91. PMID: 8863667.
      View in: PubMed
    231. Thompson A, Zhang Y, Kamen D, Jackson CW, Cardiff RD, Ravid K. Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization. J Biol Chem. 1996 Sep 20; 271(38):22976-82. PMID: 8798484.
      View in: PubMed
    232. Tulchin N, Ornstein L, Bleiweiss I, Dikman S, Cardiff R. Immunohistologic c-myc protein in benign breast disease and cancer. Int J Oncol. 1996 Sep; 9(3):419-25. PMID: 21541529.
      View in: PubMed
    233. Liang TJ, Reid AE, Xavier R, Cardiff RD, Wang TC. Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. J Clin Invest. 1996 Jun 15; 97(12):2872-7. PMID: 8675700.
      View in: PubMed
    234. Guy CT, Cardiff RD, Muller WJ. Activated neu induces rapid tumor progression. J Biol Chem. 1996 Mar 29; 271(13):7673-8. PMID: 8631805.
      View in: PubMed
    235. Cardiff RD. The biology of mammary transgenes: five rules. J Mammary Gland Biol Neoplasia. 1996 Jan; 1(1):61-73. PMID: 10887481.
      View in: PubMed
    236. Webster MA, Cardiff RD, Muller WJ. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. Proc Natl Acad Sci U S A. 1995 Aug 15; 92(17):7849-53. PMID: 7544006.
      View in: PubMed
    237. Tulchin N, Lee F, Ornstein L, Strauchen J, Cardiff R. C-myc protein distribution - mammary adenocarcinomas of mtv/myc transgenic mice. Int J Oncol. 1995 Jul; 7(1):5-9. PMID: 21552798.
      View in: PubMed
    238. Munn RJ, Webster M, Muller WJ, Cardiff RD. Histopathology of transgenic mouse mammary tumors (a short atlas). Semin Cancer Biol. 1995 Jun; 6(3):153-8. PMID: 7495983.
      View in: PubMed
    239. Cardiff RD, Munn RJ. Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Lett. 1995 Mar 23; 90(1):13-9. PMID: 7720037.
      View in: PubMed
    240. Cardiff RD. Cathepsin D and breast cancer: useful? Hum Pathol. 1994 Sep; 25(9):847-8. PMID: 8088757.
      View in: PubMed
    241. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994 Jun 23; 369(6482):669-71. PMID: 8208295.
      View in: PubMed
    242. Bratthauer GL, Cardiff RD, Fanning TG. Expression of LINE-1 retrotransposons in human breast cancer. Cancer. 1994 May 01; 73(9):2333-6. PMID: 8168038.
      View in: PubMed
    243. Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Biltz R, Morris CF, Pierce GF. Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor. Am J Pathol. 1994 May; 144(5):862-8. PMID: 8178937.
      View in: PubMed
    244. Shen MM, Skoda RC, Cardiff RD, Campos-Torres J, Leder P, Ornitz DM. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 1994 Mar 15; 13(6):1375-85. PMID: 8137821.
      View in: PubMed
    245. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 1994 Jan; 8(1):23-32. PMID: 7507074.
      View in: PubMed
    246. Imam SA, Esteban EF, Chen RS, Cardiff RD, Taylor CR. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer. Cancer Res. 1993 Jul 15; 53(14):3233-6. PMID: 7686814.
      View in: PubMed
    247. Cardiff RD, Leder A, Kuo A, Pattengale PK, Leder P. Multiple tumor types appear in a transgenic mouse with the ras oncogene. Am J Pathol. 1993 Apr; 142(4):1199-207. PMID: 8475993.
      View in: PubMed
    248. Cardiff RD, Muller WJ. Transgenic mouse models of mammary tumorigenesis. Cancer Surv. 1993; 16:97-113. PMID: 8394206.
      View in: PubMed
    249. Benvenisty N, Ornitz DM, Bennett GL, Sahagan BG, Kuo A, Cardiff RD, Leder P. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Oncogene. 1992 Dec; 7(12):2399-405. PMID: 1461648.
      View in: PubMed
    250. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A. 1992 Nov 15; 89(22):10578-82. PMID: 1359541.
      View in: PubMed
    251. Ornitz DM, Cardiff RD, Kuo A, Leder P. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. J Natl Cancer Inst. 1992 Jun 03; 84(11):887-92. PMID: 1317463.
      View in: PubMed
    252. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992 Mar; 12(3):954-61. PMID: 1312220.
      View in: PubMed
    253. Donald PJ, Cardiff RD, He DE, Kendall K. Monoclonal antibody-porphyrin conjugate for head and neck cancer: the possible magic bullet. Otolaryngol Head Neck Surg. 1991 Dec; 105(6):781-7. PMID: 1787967.
      View in: PubMed
    254. Aguilar-Cordova E, Strange R, Young LJ, Billy HT, Gumerlock PH, Cardiff RD. Viral Ha-ras mediated mammary tumor progression. Oncogene. 1991 Sep; 6(9):1601-7. PMID: 1923527.
      View in: PubMed
    255. Cardiff RD, Sinn E, Muller W, Leder P. Transgenic oncogene mice. Tumor phenotype predicts genotype. Am J Pathol. 1991 Sep; 139(3):495-501. PMID: 1887859.
      View in: PubMed
    256. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A. 1990 Dec; 87(23):9178-82. PMID: 2251261.
      View in: PubMed
    257. Morris DW, Barry PA, Bradshaw HD, Cardiff RD. Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain. J Virol. 1990 Apr; 64(4):1794-802. PMID: 2157060.
      View in: PubMed
    258. Strange R, Aguilar-Cordova E, Young LJ, Billy HT, Dandekar S, Cardiff RD. Harvey-ras mediated neoplastic development in the mouse mammary gland. Oncogene. 1989 Mar; 4(3):309-15. PMID: 2784851.
      View in: PubMed
    259. Morris DW, Bradshaw HD, Billy HT, Munn RJ, Cardiff RD. Isolation of a pathogenic clone of mouse mammary tumor virus. J Virol. 1989 Jan; 63(1):148-58. PMID: 2535722.
      View in: PubMed
    260. Cardiff RD, Aguilar-Cordova E. Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia. Anticancer Res. 1988 Sep-Oct; 8(5A):925-33. PMID: 2845853.
      View in: PubMed
    261. Cardiff RD, Gumerlock PH, Soong MM, Dandekar S, Barry PA, Young LJ, Meyers FJ. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene. 1988 Aug; 3(2):205-13. PMID: 2842717.
      View in: PubMed
    262. Baker WC, deVere White R, Rossitto PV, Min BH, Cardiff RD. Quantitative analysis of keratin 18 in the urine of patients with bladder cancer. J Urol. 1988 Aug; 140(2):436-9. PMID: 2456406.
      View in: PubMed
    263. Rossitto PV, Chan R, Strand MA, Miller CH, Baker WC, Deitch AD, deVere White R, Cardiff RD. Characterization of urinary keratin number 18 using a new assay. J Urol. 1988 Aug; 140(2):431-5. PMID: 2456405.
      View in: PubMed
    264. Chan R, Edwards BF, Hu R, Rossitto PV, Min BH, Lund JK, Cardiff RD. Characterization of two monoclonal antibodies in an immunohistochemical study of keratin 8 and 18 expression. Am J Clin Pathol. 1988 Apr; 89(4):472-80. PMID: 2451420.
      View in: PubMed
    265. Cardiff RD. Cellular and molecular aspects of neoplastic progression in the mammary gland. Eur J Cancer Clin Oncol. 1988 Jan; 24(1):15-20. PMID: 3276529.
      View in: PubMed
    266. Lanphear JH, Cardiff RD. Faculty development. An essential consideration in curriculum change. Arch Pathol Lab Med. 1987 May; 111(5):487-91. PMID: 3566481.
      View in: PubMed
    267. Ehmann UK, Guzman RC, Osborn RC, Young JT, Cardiff RD, Nandi S. Cultured mouse mammary epithelial cells: normal phenotype after implantation. J Natl Cancer Inst. 1987 Apr; 78(4):751-7. PMID: 3470550.
      View in: PubMed
    268. Louie S, Cross CE, Amott TR, Cardiff R. Postirradiation malignant fibrous histiocytoma of the trachea. Am Rev Respir Dis. 1987 Mar; 135(3):761-2. PMID: 3030170.
      View in: PubMed
    269. Dandekar S, Rossitto P, Pickett S, Mockli G, Bradshaw H, Cardiff R, Gardner M. Molecular characterization of the Akvr-1 restriction gene: a defective endogenous retrovirus-borne gene identical to Fv-4r. J Virol. 1987 Feb; 61(2):308-14. PMID: 3027362.
      View in: PubMed
    270. Smith GH, Young LJ, Benjamini F, Medina D, Cardiff RD. Proteins antigenically related to peptides encoded by the mouse mammary tumour virus long terminal repeat sequence are associated with intracytoplasmic A particles. J Gen Virol. 1987 Feb; 68 ( Pt 2):473-86. PMID: 3029286.
      View in: PubMed
    271. Pathak VK, Strange R, Young LJ, Morris DW, Cardiff RD. Survey of int region DNA rearrangements in C3H and BALB/cfC3H mouse mammary tumor system. J Natl Cancer Inst. 1987 Feb; 78(2):327-31. PMID: 3468297.
      View in: PubMed
    272. Chan R, Rossitto PV, Edwards BF, Cardiff RD. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells. Cancer Res. 1986 Dec; 46(12 Pt 1):6353-9. PMID: 2430694.
      View in: PubMed
    273. Dandekar S, Sukumar S, Zarbl H, Young LJ, Cardiff RD. Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors. Mol Cell Biol. 1986 Nov; 6(11):4104-8. PMID: 3099168.
      View in: PubMed
    274. Cardiff RD. Teaching problem solving in pathology. General Professional Education of Physicians (GPEP) anticipated. Arch Pathol Lab Med. 1986 Sep; 110(9):780-3. PMID: 3755887.
      View in: PubMed
    275. Meyers FJ, Cardiff RD, Quadro R, Gribble M, Kohler M, Medrano V, Mitchell EP, Shiffman R, William L. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. Cancer Treat Rep. 1986 Jun; 70(6):805-6. PMID: 2425963.
      View in: PubMed
    276. Morris DW, Young LJ, Gardner MB, Cardiff RD. Transfer, by selective breeding, of the pathogenic Mtv-2 endogenous provirus from the GR strain to a wild mouse line free of endogenous and exogenous mouse mammary tumor virus. J Virol. 1986 May; 58(2):247-52. PMID: 3009842.
      View in: PubMed
    277. Gardner M, Dandekar S, Cardiff R. Molecular mechanism of an ecotropic MuLV restriction gene Akvr-1/FV-4 in California wild mice. Curr Top Microbiol Immunol. 1986; 127:338-45. PMID: 3015498.
      View in: PubMed
    278. Fanning TG, Hu WS, Cardiff RD. Analysis of tissue-specific methylation patterns of mouse mammary tumor virus DNA by two-dimensional Southern blotting. J Virol. 1985 Jun; 54(3):726-30. PMID: 2987526.
      View in: PubMed
    279. Fanning TG, Morris DW, Cardiff RD, Bradshaw HD. Characterization of an endogenous retrovirus-repetitive DNA chimera in the mouse genome. J Virol. 1985 Mar; 53(3):998-1000. PMID: 2983106.
      View in: PubMed
    280. Gardner MB, Malone RW, Morris DW, Young LJ, Strange R, Cardiff RD, Faulkin LJ, Mitchell DJ. Mammary tumors in feral mice lacking MuMTV DNA. J Exp Pathol. 1985; 2(2):93-8. PMID: 3023583.
      View in: PubMed
    281. Young LJ, DeOme KB, Blair PB, Pitelka DR, Cardiff RD. Development and characterization of the BALB/cNIV mouse strain. Cancer Res. 1984 Oct; 44(10):4333-6. PMID: 6088036.
      View in: PubMed
    282. Faulkin LJ, Mitchell DJ, Young LJ, Morris DW, Malone RW, Cardiff RD, Gardner MB. Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus. J Natl Cancer Inst. 1984 Oct; 73(4):971-82. PMID: 6090752.
      View in: PubMed
    283. Brabon AC, Williams JF, Cardiff RD. A monoclonal antibody to a human breast tumor protein released in response to estrogen. Cancer Res. 1984 Jun; 44(6):2704-10. PMID: 6426784.
      View in: PubMed
    284. Meyers FJ, Cardiff RD, Taylor CR, Zuniga M, Radich J. Hairy cell leukemia has a B-cell genotype. Hematol Oncol. 1984 Apr-Jun; 2(2):145-50. PMID: 6430776.
      View in: PubMed
    285. Hu WS, Fanning TG, Cardiff RD. Mouse mammary tumor virus: specific methylation patterns of proviral DNA in normal mouse tissues. J Virol. 1984 Jan; 49(1):66-71. PMID: 6317895.
      View in: PubMed
    286. Cardiff RD. Protoneoplasia: the molecular biology of murine mammary hyperplasia. Adv Cancer Res. 1984; 42:167-90. PMID: 6098147.
      View in: PubMed
    287. Cardiff RD, Morris DW, Young LJ. Alterations of acquired mouse mammary tumor virus DNA during mammary tumorigenesis in BALB/cfC3H mice. J Natl Cancer Inst. 1983 Nov; 71(5):1011-9. PMID: 6316008.
      View in: PubMed
    288. Faulkin LJ, Mitchell DJ, Cardiff RD, Rosenblatt LS, Goldman M. Effects of X irradiation on the growth of normal and hyperplastic mouse mammary gland transplants. Radiat Res. 1983 May; 94(2):390-403. PMID: 6190194.
      View in: PubMed
    289. Wheeler DA, Butel JS, Medina D, Cardiff RD, Hager GL. Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol. 1983 Apr; 46(1):42-9. PMID: 6298469.
      View in: PubMed
    290. Greenberg BR, Miller C, Cardiff RD, MacKenzie MR, Walling P. Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders. Br J Haematol. 1983 Jan; 53(1):125-33. PMID: 6216909.
      View in: PubMed
    291. Cardiff RD, Taylor CR, Wellings SR, Colcher D, Schlom J. Monoclonal antibodies in immunoenzyme studies of breast cancer. Ann N Y Acad Sci. 1983; 420:140-6. PMID: 6372587.
      View in: PubMed
    292. Ashley RL, Cardiff RD, Pratt TS, Faulkin LJ. A high-tumor-incidence subline of the D1 mouse mammary hyperplastic outgrowth line: effect of carcinogens. J Natl Cancer Inst. 1982 Sep; 69(3):639-45. PMID: 6287083.
      View in: PubMed
    293. Puma JP, Fanning TG, Young LJ, Cardiff RD. Identification of a unique mouse mammary tumor virus in the BALB/cNIV mouse strain. J Virol. 1982 Jul; 43(1):158-65. PMID: 6286994.
      View in: PubMed
    294. Altrock BW, Cardiff RD, Puma JP, Lund JK. Detection of acquired provirus sequences in mammary tumors from low-expressor, low-risk mice. J Natl Cancer Inst. 1982 Jun; 68(6):1037-41. PMID: 6283224.
      View in: PubMed
    295. Faulkin LJ, Mitchell DJ, Cardiff RD, Goldman M. Survival of mouse mammary gland transplants of normal, hyperplastic, and tumor tissues exposed to X-rays. J Natl Cancer Inst. 1982 Apr; 68(4):613-8. PMID: 6951077.
      View in: PubMed
    296. Fanning TG, Vassos AB, Cardiff RD. Methylation and amplification of mouse mammary tumor virus DNA in normal, premalignant, and malignant cells of GR/A mice. J Virol. 1982 Mar; 41(3):1007-13. PMID: 6284957.
      View in: PubMed
    297. Vacquier JP, Cardiff RD, Blair PB. Immunological characterization of a low oncogenic mouse mammary tumor virus BALB/cNIV mice. J Virol. 1981 Oct; 40(1):56-64. PMID: 6169849.
      View in: PubMed
    298. Cardiff RD, Fanning TG, Morris DW, Ashley RL, Faulkin LJ. Restriction endonuclease studies of hyperplastic outgrowth lines from BALB/cfC3H mouse hyperplastic mammary nodules. Cancer Res. 1981 Aug; 41(8):3024-9. PMID: 6265073.
      View in: PubMed
    299. Altrock BW, Cardiff RD, Blair PB. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development. J Natl Cancer Inst. 1981 Jul; 67(1):163-8. PMID: 6265680.
      View in: PubMed
    300. Fanning TG, Puma JP, Cardiff RD. Identification and partial characterization of an endogenous form of mouse mammary tumor virus that is transcribed into the virion-associated RNA genome. Nucleic Acids Res. 1980 Dec 11; 8(23):5715-23. PMID: 6258150.
      View in: PubMed
    301. Ashley RL, Cardiff RD, Fanning TG. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth. J Natl Cancer Inst. 1980 Nov; 65(5):977-86. PMID: 6253710.
      View in: PubMed
    302. Ashley RL, Cardiff RD, Mitchell DJ, Faulkin LJ, Lund JK. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules. Cancer Res. 1980 Nov; 40(11):4232-42. PMID: 6258774.
      View in: PubMed
    303. Fanning TG, Puma JP, Cardiff RD. Selective amplification of mouse mammary tumor virus in mammary tumors of GR mice. J Virol. 1980 Oct; 36(1):109-14. PMID: 6255199.
      View in: PubMed
    304. Drohan W, Cardiff RD, Lund JK, Schlom J. Correlation between the detection of specific mouse mammary tumor proviral sequences and the presence of pulmonary metastases in mice bearing spontaneous mammary tumors. Cancer Res. 1980 Jul; 40(7):2316-22. PMID: 6248203.
      View in: PubMed
    305. Gardner MB, Lund JK, Cardiff RD. Prevalence and distribution of murine mammary tumor virus antigen detectable by immunocytochemistry in spontaneous breast tumors of wild mice. J Natl Cancer Inst. 1980 May; 64(5):1251-7. PMID: 6245303.
      View in: PubMed
    306. Altrock BW, Cardiff RD. Mouse mammary tumor virus infections: viral expression and tumor risk. J Natl Cancer Inst. 1979 Oct; 63(4):1075-80. PMID: 225501.
      View in: PubMed
    307. St George JA, Cardiff RD, Young LJ, Faulkin LJ. Immunocytochemical distribution of mouse mammary tumor virus antigens in BALB/cfC3H mammary epithelium. J Natl Cancer Inst. 1979 Sep; 63(3):813-20. PMID: 224238.
      View in: PubMed
    308. Vacquier JP, Cardiff RD. In vitro infectivity assay for mouse mammary tumor virus. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):4117-21. PMID: 226995.
      View in: PubMed
    309. Cohen JC, Shank PR, Morris VL, Cardiff R, Varmus HE. Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse. Cell. 1979 Feb; 16(2):333-45. PMID: 222456.
      View in: PubMed
    310. Young LJ, Cardiff RD, Seeley T. Quantitative characterization of domes in primary mouse mammary epithelial tumor cell cultures. In Vitro. 1978 Nov; 14(11):895-902. PMID: 569637.
      View in: PubMed
    311. Cardiff RD, Puentes MJ, Young LJ, Smith GH, Teramoto YA, Altrock BW, Pratt TS. Serological and biochemical characterization of the mouse mammary tumor virus with localization of p10. Virology. 1978 Mar; 85(1):157-67. PMID: 205999.
      View in: PubMed
    312. Cardiff RD, Wellings SR, Faulkin LJ. Biology of breast preneoplasia. Cancer. 1977 Jun; 39(6 Suppl):2734-46. PMID: 194676.
      View in: PubMed
    313. Teramoto YA, Cardiff RD, Lund JK. The structure of the mouse mammary tumor virus: isolation and characterization of the core. Virology. 1977 Mar; 77(1):135-48. PMID: 65834.
      View in: PubMed
    314. Ashley RL, Cardiff RD, Manning JS. Characterization of a terminal deoxynucleotidyl transferase activity in mouse mammary tumor virus. Virology. 1977 Mar; 77(1):367-75. PMID: 65836.
      View in: PubMed
    315. Ringold GM, Cardiff RD, Varmus HE, Yamamoto KR. Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell. 1977 Jan; 10(1):11-8. PMID: 189932.
      View in: PubMed
    316. Cardiff RD, Lund JK. Distribution of dengue-2 antigens by electron immunocytochemistry. Infect Immun. 1976 Jun; 13(6):1699-709. PMID: 786880.
      View in: PubMed
    317. Newgard KW, Cardiff RD, Blair PB. Human antibodies binding to the mouse mammary tumor virus: a nonspecific reaction? Cancer Res. 1976 Feb; 36(2 pt 2):765-8. PMID: 943235.
      View in: PubMed
    318. Cardiff RD, Young LJ, Ashley RL. Hormone synergism in the in vitro production of the mouse mammary tumor virus. J Toxicol Environ Health Suppl. 1976; 1:117-29. PMID: 186627.
      View in: PubMed
    319. Young LJ, Cardiff RD, Ashley RL. Long-term primary culture of mouse mammary tumor cells: production of virus. J Natl Cancer Inst. 1975 May; 54(5):1215-21. PMID: 165313.
      View in: PubMed
    320. Cardiff RD, Puentes MJ, Teramoto YA, Lund JK. Structure of the mouse mammary tumor virus: characterization of bald particles. J Virol. 1974 Nov; 14(5):1293-303. PMID: 4372399.
      View in: PubMed
    321. Teramoto YA, Puentes MJ, Young LJ, Cardiff RD. Structure of the mouse mammary tumor virus: polypeptides and glycoproteins. J Virol. 1974 Feb; 13(2):411-8. PMID: 4359300.
      View in: PubMed
    322. Cardiff RD. Quantitation of mouse mammary tumor virus (MTV) virions by radioimmunoassay. J Immunol. 1973 Dec; 111(6):1722-9. PMID: 4356324.
      View in: PubMed
    323. Cardiff RD, Russ SB, Brandt WE, Russell PK. Cytological localization of Dengue-2 antigens: an immunological study with ultrastructural correlation. Infect Immun. 1973 May; 7(5):809-16. PMID: 4202963.
      View in: PubMed
    324. Warkel RL, Rinaldi CF, Bancroft WH, Cardiff RD, Holmes GE, Wilsnack RE. Fatal acute meningoencephalitis due to lymphocytic choriomeningitis virus. Neurology. 1973 Feb; 23(2):198-203. PMID: 4568992.
      View in: PubMed
    325. Cardiff RD, Dalrymple JM, Russell PK. RNA polymerase in group B arbovirus (dengue-2) infected cells. Brief report. Arch Gesamte Virusforsch. 1973; 40(3):392-6. PMID: 4633585.
      View in: PubMed
    326. Dalrymple JM, Teramoto AY, Cardiff RD, Russell PK. Radioimmune precipitation of group A arboviruses. J Immunol. 1972 Sep; 109(3):426-33. PMID: 5066343.
      View in: PubMed
    327. McCloud TG, Cardiff RD, Brandt WE, Chiewsilp D, Russell PK. Separation of dengue strains on the basis of a nonstructural antigen. Am J Trop Med Hyg. 1971 Nov; 20(6):964-8. PMID: 5002249.
      View in: PubMed
    328. Shapiro D, Brandt WE, Cardiff RD, Russell PK. The proteins of Japanese encephalitis virus. Virology. 1971 Apr; 44(1):108-24. PMID: 4999121.
      View in: PubMed
    329. Cardiff RD, Brandt WE, McCloud TG, Shapiro D, Russell PK. Immunological and biophysical separation of dengue-2 antigens. J Virol. 1971 Jan; 7(1):15-23. PMID: 5543428.
      View in: PubMed
    330. Misfeldt DS, Cardiff RD, Wellings SR. The ultrastructural distribution of several phosphatase enzymes in mouse mammary tumor system. Lab Invest. 1970 Dec; 23(6):640-8. PMID: 4320839.
      View in: PubMed
    331. Brandt WE, Cardiff RD, Russell PK. Dengue virions and antigens in brain and serum of infected mice. J Virol. 1970 Oct; 6(4):500-6. PMID: 5497897.
      View in: PubMed
    332. McCloud TG, Brandt WE, Russell PK. Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. Virology. 1970 Jul; 41(3):569-72. PMID: 4912826.
      View in: PubMed
    333. Manning JS, Hackett AJ, Cardiff RD, Mel HC, Blair PB. Isopycnic zonal centrifugation and characterization of the mouse mammary tumor virus (MTV) in different gradient solutions. Virology. 1970 Apr; 40(4):912-9. PMID: 4194176.
      View in: PubMed
    334. Cardiff RD, Blair PB. In vitro cultivation of the mouse mammary tumor virus: correlation of infectivity and morphology with radioisotope studies. Int J Cancer. 1970 Mar 15; 5(2):211-6. PMID: 4317727.
      View in: PubMed
    335. Duesberg PH, Cardiff RD. Structural relationships between the RNA of mammary tumor virus and those of other RNA tumor viruses. Virology. 1968 Dec; 36(4):696-700. PMID: 4302009.
      View in: PubMed
    336. Cardiff RD, Blair PR, DeOme KB. In vitro cultivation of the mouse mammary tumor virus: replication of MTV in tissue culture. Virology. 1968 Oct; 36(2):313-7. PMID: 4300884.
      View in: PubMed
    337. Cardiff RD, Blair PB, Nakayama P. In vitro cultivation of mouse mammary tumor virus: detection of MTV production by radioisotope labeling and identification by immune precipitation. Proc Natl Acad Sci U S A. 1968 Mar; 59(3):895-902. PMID: 4296043.
      View in: PubMed
    338. Cooper RA, Cardiff RD, Wellings SR. Ultrastructure of vaginal keratinization in estrogen treated immature BALB/cCRGL mice. Z Zellforsch Mikrosk Anat. 1967; 77(3):377-403. PMID: 5599619.
      View in: PubMed
    339. Cardiff RD. A histochemical and electron microscopic study of skeletal muscle in a case of Pompe's disease (glycogenosis II). Pediatrics. 1966 Feb; 37(2):249-59. PMID: 4221626.
      View in: PubMed